I think we can all agree that allergy season is the worst. You are supposed to *finally* be running outside again or picnicking in the park, but instead, you are stuck inside trying to breathe through snot and see through watery, itchy eyes.
Allergy symptoms—those watery eyes and stuffy nose, along with sneezing fits, coughing, wheezing, and hive- or eczema-like rashes—happen when your immune system essentially freaks out over an otherwise harmless substance (like pollen). Delightful, huh?
Allergy Therapeutics (LON:AGY) is an international commercial biotechnology group focused on the treatment and diagnosis of allergic disorders, including immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third-party products from its subsidiaries in nine major European countries and via distribution agreements in an additional fourteen countries. Its broad pipeline of products in clinical development include vaccines for grass, tree and house dust mite, and peanut allergy vaccine in pre-clinical development. Adjuvant systems to boost performance of vaccines outside allergy are also in development.